Trump's tariffs will not only impact sponsors, but higher costs will ripple down the clinical trial supply chain in the US.

The debate over pharmaceutical advertising on television has resurfaced with renewed vigor, among populist conservatives and activists, such ...

Foreign participants at the 16th Asia Pharma Expo foresee a bright future for Bangladesh’s pharmaceutical industry, given its ...

Blockchain is poised to redefine pharmaceutical validation, offering unparalleled improvements in data integrity, compliance, ...

DMU will be part of a consortium laying the foundation for future medicines that are affordable, safe, effective, and ...

Pharmaceutical company Takeda is pioneering a technology-enabled, patient-centered future for plasma-derived therapies ...

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the ...

Halozyme Therapeutics, Inc. (NASDAQ:HALO) is a biopharmaceutical company focused on innovative drug delivery technologies, primarily through its Enhaze platform. This technology, based on the rHuPH20 ...

The number of clinical trials in which AI designed or repurposed molecules, or targeted diseases, has more than doubled since ...

Deborah McElhone, Head of Sustainability (Pharma) from CPI, argues that process intensification is a game changer for the ...

Vietnam’s amended Law on Pharmacy, set to take effect on July 1, 2025, introduces key reforms to modernize the pharmaceutical ...